4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Edgewise Therapeutics, Inc. (EWTX) operates in the Biotechnology industry and is headquartered in Boulder, United States with about 154 employees. Its market capitalization is roughly $5 billion. In the fiscal year ended 2025-12-31, EWTX reported $0M in revenue and ($168M) in net income.
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($191M) | ($159M) | ($114M) | ($72M) |
| Net Income | ($168M) | ($134M) | ($100M) | ($68M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($54M) | ($56M) | ($47M) | ($43M) | ($46M) |
| Net Income | ($49M) | ($50M) | ($41M) | ($36M) | ($41M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $553M | $487M | $340M | $367M | — |
| Total Liabilities | $30M | $28M | $21M | $20M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EWTX viewer.
About TickerBase · Data methodology & sources